Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Frejus J Zinsou"'
Autor:
Yoanne D Mouwenda, Madeleine E Betouke Ongwe, Friederike Sonnet, Koen A Stam, Lucja A Labuda, Sophie De Vries, Martin P Grobusch, Frejus J Zinsou, Yabo J Honkpehedji, Jean-Claude Dejon Agobe, David J Diemert, Remko van Leeuwen, Maria E Bottazzi, Peter J Hotez, Peter G Kremsner, Jeffrey M Bethony, Simon P Jochems, Ayola A Adegnika, Marguerite Massinga Loembe, Maria Yazdanbakhsh
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 10, p e0009732 (2021)
Two hookworm vaccine candidates, Na-GST-1 and Na-APR-1, formulated with Glucopyranosyl Lipid A (GLA-AF) adjuvant, have been shown to be safe, well tolerated, and to induce antibody responses in a Phase 1 clinical trial (Clinicaltrials.gov NCT02126462
Externí odkaz:
https://doaj.org/article/74b241e8340f43ffaff17b49d024c36c
Autor:
Bayode R. Adegbite, Jean R. Edoa, Yabo J. Honkpehedji, Frejus J. Zinsou, Jean C. Dejon-Agobe, Mirabeau Mbong-Ngwese, Fabrice Lotola-Mougueni, Erik Koehne, Albert Lalremruata, Andrea Kreidenweiss, The T. Nguyen, Jutta Kun, Selidji T. Agnandji, Bertrand Lell, Abdou R. Safiou, Fridia A. Obone Atome, Ghyslain Mombo-Ngoma, Michael Ramharter, Thirumalaisamy P. Velavan, Benjamin Mordmüller, Peter G. Kremsner, Ayola A. Adegnika
Publikováno v:
Malaria Journal, Vol 18, Iss 1, Pp 1-9 (2019)
Abstract Background Malaria remains a major public health problem, affecting mainly low-and middle-income countries. The management of this parasitic disease is challenged by ever increasing drug resistance. This study, investigated the therapeutic e
Externí odkaz:
https://doaj.org/article/d16288ba442942598e824b48025d8d77
Autor:
Michael Ramharter, Bayode Romeo Adegbite, Mirabeau Mbong-Ngwese, Albert Lalremruata, Peter G. Kremsner, Fabrice Lotola-Mougueni, Fridia A. Obone Atome, Abdou R. Safiou, Selidji T Agnandji, Andrea Kreidenweiss, Benjamin Mordmüller, Yabo Josiane Honkpehedji, Ghyslain Mombo-Ngoma, Jean Claude Dejon-Agobé, Thirumalaisamy P. Velavan, Frejus J. Zinsou, Jean Ronald Edoa, J. F. J. Kun, Ayola A. Adegnika, Bertrand Lell, Erik Koehne
Publikováno v:
Malaria journal, 18(1):424. BioMed Central
Malaria Journal, Vol 18, Iss 1, Pp 1-9 (2019)
Malaria Journal
Malaria Journal, Vol 18, Iss 1, Pp 1-9 (2019)
Malaria Journal
Background Malaria remains a major public health problem, affecting mainly low-and middle-income countries. The management of this parasitic disease is challenged by ever increasing drug resistance. This study, investigated the therapeutic efficacy,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aba32c4a5378296d23d2ed211b49a504
https://pure.amc.nl/en/publications/monitoring-of-efficacy-tolerability-and-safety-of-artemetherlumefantrine-and-artesunateamodiaquine-for-the-treatment-of-uncomplicated-plasmodium-falciparum-malaria-in-lambarene-gabon(4f237ee7-a131-49e3-87f5-26dd0376119f).html
https://pure.amc.nl/en/publications/monitoring-of-efficacy-tolerability-and-safety-of-artemetherlumefantrine-and-artesunateamodiaquine-for-the-treatment-of-uncomplicated-plasmodium-falciparum-malaria-in-lambarene-gabon(4f237ee7-a131-49e3-87f5-26dd0376119f).html